See all Best Diagnostics Stocks 2026

Thermo Fisher Scientific (TMO) Stock: Buy, Sell, or Hold?

TMO - Thermo Fisher Scientific, Inc.

MEASURING & CONTROLLING DEVICES, NEC
$673.82
-2.72 (-0.40%) â–ŧ
5d: -2.34%
30d: -0.67%
90d: +20.43%
WAIT
LOW Confidence
Protect Your TMO Gains
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Oct 21, 2026 0d
Smart Money Accumulation

Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →

Signal fired Oct 16, 2026 at $686.49 · last confirmed Oct 23, 2026

Strength: 5.0/10

Get Alerted When TMO Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡
Bottom Line:
ℹī¸ NEUTRAL: TMO is fairly priced but lacks strong directional signals. At 5.6% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$799.34
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$496.33
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.6x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: TMO is currently trading at $673.82, which is considered fair relative to its 30-day fair value range of $649.36 to $683.28. From a valuation perspective, the stock is trading at a premium (Forward PE: 24.3) compared to its historical average (20.6). At these levels, the market is pricing in 5.6% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, TMO is in a strong uptrend. Immediate support is located at $652.50, while resistance sits at $705.78.

Market Sentiment: TMO scores 36/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $750.92 (+11.4%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $649.36 - $683.28
Company Quality Score 48/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 46.7%

Protect Your Profits

Holding TMO? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • NEUTRAL: Price in fair range
  • BEARISH: Weak technical setup (36/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading below Wall St target ($750.92)
  • NEUTRAL: Trading at premium valuation - market expects 5.6% growth which is achievable
  • WARNING: Composite score 48/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $649.36 - $683.28
Current vs Trading Range FAIR

Support & Resistance Levels

Support Level $652.50
Resistance Level $705.79
Current Trend Strong Uptrend
Technical data as of Oct 23, 2026

Fundamental Context

Forward P/E (Next Year Est.) 24.28
Wall Street Target $750.92 (+11.4%)
Revenue Growth (YoY) 9.1%
Earnings Growth (YoY) 8.7%
Profit Margin 14.9%
Valuation Premium vs History +5.6% premium
PE vs Historical 24.3 vs 20.6 STRETCHED
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +5.6% (market-implied from PE analysis)
1-Year Target $711.55 (+6%)
2-Year Target $751.40 (+12%)
3-Year Target $793.48 (+18%)
3-Yr Target (if PE normalizes) (PE: 24→21) PE COMPRESSION $673.34 (0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 24.3, Growth: 9.9%) $894.79 (+33%)
Base: (SPY PE: 19.9, Growth: 9.9%) $732.03 (+9%)
Bear: (PE: 16.9, Growth: 9.9%) $622.23 (-8%)
📈 Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (37x PE), but valuation improves significantly next year (24x PE) as earnings recover.
Trailing PE: 36.60 | Current EPS (TTM): $18.96
Bull Case $1111.52 (+64%)
Analyst growth 45.6%, PE expands to 40.3
Base Case $1010.48 (+49%)
Market implied 45.6%, PE stable at 36.6
Bear Case $471.93 (-30%)
Severe decline -20.0%, PE contracts to 31.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: October 23, 2026 5:34 PM ET
Data refreshes hourly during market hours. Next update: 6:34 PM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
See Full Scanner Results »
Technical Signals Check

Is TMO showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for TMO.

Create Free Account

Already have an account? Log In

Featured in Portfolios

TMO is a key holding in these high-performance investment strategies.

Healthcare Giants Sector • +24.8% Return
42
View All Strategies

Top Rated Diagnostics & Research Stocks

Top-rated stocks in Diagnostics & Research by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
GH
Guardant Health Inc 		STRONG BUY
26 analysts 		$202 67 BUY
EXAS
EXACT Sciences Corporatiâ€Ļ 		STRONG BUY
26 analysts 		$106 52 HOLD
NTRA
Natera Inc 		STRONG BUY
23 analysts 		$404 54 HOLD
DHR
Danaher Corporation 		STRONG BUY
25 analysts 		$244 45 HOLD
IQV
IQVIA Holdings Inc 		STRONG BUY
22 analysts 		$299 50 HOLD
GH Guardant Health Iâ€Ļ
67 BUY
EXAS EXACT Sciences Coâ€Ļ
52 HOLD
NTRA Natera Inc
54 HOLD
DHR Danaher Corporatiâ€Ļ
45 HOLD
IQV IQVIA Holdings Inc
50 HOLD

Advanced TMO Option Strategies

Professional options setups generated by AI based on today's TMO price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for TMO

TMO Technical Chart TMO Price Prediction TMO Earnings Date TMO Investment Advisor TMO Fair Price Analyzer TMO Options Advisor TMO Options Chain TMO Options Analysis TMO Competitors
Compare TMO with Peers
TMO vs DHR
Which one to buy?
TMO vs SYK
Which one to buy?
TMO vs ZTS
Which one to buy?
TMO vs BDX
Which one to buy?
TMO vs ISRG
Which one to buy?
TMO vs ZTS
Winner: TMO
TMO vs MTD
Winner: TMO
TMO vs LH
Winner: TMO
OWLT vs TMO
TMO vs ONTO
TMO vs A
Winner: TMO
TMO vs TRMB
ROK vs TMO
TMO vs IQV
Winner: TMO
TMO vs BDX
Create New Comparison View All Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals